Carregant...
Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
Tigilanol tiglate is a novel small molecule approved as a veterinary pharmaceutical in Europe for intratumoural treatment of non-metastatic, non-resectable canine mast cell tumors. The drug has a “tumor agnostic” mode of action associated with induction of an acute inflammatory response at the treat...
Guardat en:
| Publicat a: | Front Vet Sci |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7509040/ https://ncbi.nlm.nih.gov/pubmed/33033726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2020.00639 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|